DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
DRMA Filings
Filing Date
Form Description
Form Type
2025-11-24
Form S-3 - Registration statement under Securities Act of 1933
2025-11-24 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-11-18
Form 8-K - Current report
Key Events
2025-11-18 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-11-07
Form 8-K - Current report
Key Events
2025-11-07 · Key Events
Form 8-K - Current report
2025-11-07
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-07 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-09-17
Form 8-K - Current report
Key Events
2025-09-17 · Key Events
Form 8-K - Current report
2025-09-10
Form 8-K - Current report
Key Events
2025-09-10 · Key Events
Form 8-K - Current report
2025-08-25
Form 8-K - Current report
Key Events
2025-08-25 · Key Events
Form 8-K - Current report
2025-08-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
